Background
Patients and Methods
Results and discussion
Results
Group A | Group B | Group C |
p
| ||
---|---|---|---|---|---|
Age | 66.7 ± 9.1 | 65.6 ± 8.4 | 65.3 ± 10.1 | NS | |
Sex(M/F) | 385/130 | 146/33 | 149/51 | NS | |
DM | 193(37%) | 66(37%) | 79(40%) | NS | |
HL | 241(47%) | 75(42%) | 89(45%) | NS | |
HD | 25(4.9) | 10(5.6) | 18(9.0) | NS | |
Creatinine (mg/dl) | 1.05 ± 0.53 | 1.06 ± 0.70 | 1.08 ± 0.53 | NS | |
LVEF (%) | 58 ± 13 | 54 ± 12 | 54 ± 12 | 0.006 | A vs C |
NYHA | 1.8 ± 0.8 | 1.8 ± 0.9 | 2.0 ± 0.7 | NS |
Group A | Group B | Group C |
p
| ||
---|---|---|---|---|---|
(n = 515) | (n = 179) | (n = 200) | (A vs C) | ||
Number of PCI | 0 | 1 | 3.6 ± 2.3 | ||
Extent of coronary lesion | NS | ||||
LMT(%) | 294 (57) | 108 (60) | 103 (52) | ||
1VD(%) | 4 (0) | 3 (2) | 5 (3) | ||
2VD(%) | 35 (7) | 11 (6) | 24 (12) | ||
3VD(%) | 161 (31) | 57 (32) | 68 (34) | ||
Number of grafts | 3.3 ± 1.0 | 3.4 ± 0.9 | 3.1 ± 1.0 | 0.03 | |
Number of arterial grafts | 1.9 ± 0.8 | 1.9 ± 0.8 | 1.8 ± 0.8 | NS | |
OPCAB | 58% | 50% | 53% | NS |
HR | 95% CI |
p
| |
---|---|---|---|
Survival | |||
Age | 1.034 | 1.000-10.69 | 0.049 |
Hemodialysis | 7.042 | 3.049-16.39 | < 0.0001 |
LVEF | 0.966 | 0.948-0.985 | 0.0004 |
Cardiac death | |||
Hemodialysis | 6.173 | 2.088-18.180 | 0.001 |
LVEF | 0.966 | 0.939-0.993 | 0.0143 |
number of PCI | 1.189 | 1.061-1.332 | 0.0029 |
Cardiac event | |||
Hemodialysis | 2.262 | 1.250-4.098 | 0.007 |
Number of arterial grafts | 0.729 | 0.570-0.932 | 0.012 |